Gene therapy: AAV vectors continue to deliver functional genes to patients

Vector articles of gene therapy

Smesiglutide

In 2024, where are the prospects of innovative drugs？

The world's first TIL therapy is approved for marketing

Ginkgo: Total revenue in 2023 will be US$251 million, a decrease of 47%.The bio-pharmaceutical field will be the largest market in the future